Literature DB >> 8583489

Premature rupture of membranes.

P A Poma1.   

Abstract

The management of patients with premature rupture of membranes has changed markedly in the past several years. The basis for this is a combination of a better understanding of newborn physiology, improved neonatal care, refinements in antibiotic therapy, and the widespread use of maternal and fetal monitoring. The best outcome for both mother and infant undoubtedly reflects data based on a combination of factors, among which are gestational age survival, evidence of fetal distress, presence or absence of labor and sepsis, and of course, the cervical condition as it is related to labor-readiness. An important recent advance is the recognition that an active observation management program is associated with less morbidity and mortality than the classic management course of delivery within 12 hours of membrane rupture. The fact that preterm premature rupture of membranes tends to recur in subsequent pregnancies offers an opportunity for prevention. Moreover, advances in perinatal and neonatal care will continue to improve the outcomes of these women and their children.

Entities:  

Mesh:

Year:  1996        PMID: 8583489      PMCID: PMC2607991     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  41 in total

Review 1.  Progress in pathogenesis and management of clinical intraamniotic infection.

Authors:  R S Gibbs; P Duff
Journal:  Am J Obstet Gynecol       Date:  1991-05       Impact factor: 8.661

2.  Infection and labor. III. Interleukin-1: a signal for the onset of parturition.

Authors:  R Romero; D T Brody; E Oyarzun; M Mazor; Y K Wu; J C Hobbins; S K Durum
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

3.  Logistic regression analysis of risk factors for intra-amniotic infection.

Authors:  E R Newton; T J Prihoda; R S Gibbs
Journal:  Obstet Gynecol       Date:  1989-04       Impact factor: 7.661

4.  Placental abruption in the preterm gestation: an association with chorioamnionitis.

Authors:  M J Darby; S N Caritis; S Shen-Schwarz
Journal:  Obstet Gynecol       Date:  1989-07       Impact factor: 7.661

5.  Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial.

Authors:  M M Johnston; L Sanchez-Ramos; A J Vaughn; M W Todd; G I Benrubi
Journal:  Am J Obstet Gynecol       Date:  1990-09       Impact factor: 8.661

6.  A prospective randomized study of saline solution amnioinfusion.

Authors:  J Owen; B V Henson; J C Hauth
Journal:  Am J Obstet Gynecol       Date:  1990-05       Impact factor: 8.661

7.  A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity.

Authors:  S L Hillier; J Martius; M Krohn; N Kiviat; K K Holmes; D A Eschenbach
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

8.  Saline solution amnioinfusion for oligohydramnios after premature rupture of the membranes. A preliminary report.

Authors:  M Imanaka; S Ogita; T Sugawa
Journal:  Am J Obstet Gynecol       Date:  1989-07       Impact factor: 8.661

9.  Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation.

Authors:  J M Bengtson; L J VanMarter; V A Barss; M F Greene; R E Tuomala; M F Epstein
Journal:  Obstet Gynecol       Date:  1989-06       Impact factor: 7.661

10.  Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study.

Authors:  E Amon; S V Lewis; B M Sibai; M A Villar; K L Arheart
Journal:  Am J Obstet Gynecol       Date:  1988-09       Impact factor: 8.661

View more
  2 in total

Review 1.  Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies.

Authors:  Katherine M Nelson; N'Dea Irvin-Choy; Matthew K Hoffman; Jason P Gleghorn; Emily S Day
Journal:  Adv Drug Deliv Rev       Date:  2020-09-28       Impact factor: 15.470

2.  Maternal lead exposure and premature rupture of membranes: a birth cohort study in China.

Authors:  Sha Huang; Wei Xia; Xia Sheng; Lin Qiu; Bin Zhang; Tian Chen; Shunqing Xu; Yuanyuan Li
Journal:  BMJ Open       Date:  2018-07-23       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.